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eHuman T-cell leukemia virus type 1 (HTLV-1) is the
ausative agent of two diseases: adult T-cell leukemia
ATL), a fatal T-lymphoproliferative disorder, and tropical
pastic paraparesis/HTLV-1-associated myelopathy
TSP/HAM), a chronic progressive disease of the central
ervous system. ATL was initially identified in Japan
Uchiyama et al., 1977) and is characterized by a malig-
ant proliferation of a mature T lymphocyte with a CD21,
D31, CD41, CD82, CD251, and HLA-DR1 phenotype.
eukemic cells have lobulated nuclei and are referred to
s flower cells. The association of TSP/HAM with HTLV-1
nfection was first reported by Gessain et al. (1985).
SP/HAM is characterized by a progressive demyelina-
ion of the spinal cord, but the mechanism involved in the
issue damage of the central nervous system remains
nknown. HTLV-1 has also been described to be asso-
iated with other disorders such as uveitis, arthropathy,
nfective dermatitis, and polymyositis.
Here we review recent results concerning the involve-
ent of HTLV-1 Tax protein in molecular events control-
ing cell proliferation. Taken together, these observations
rovide further insight into the mechanisms by which
TLV-1 induces cell transformation.
The expression of the HTLV-1 genome is controlled by
wo regulatory genes, the rex and tax genes, located in
he 39 region of the viral genome. Rex is a 27-kDa protein
hat acts at the posttranscriptional level by modulating
he transport of the viral RNAs and hence by promoting
he translation of unspliced and singly spliced mRNA
ncoding the gag-pol and env gene products, respec-
ively (Hidaka et al., 1988). Tax is a 40-kDa protein that
unctions in association with the activating transcription
actor/CRE-binding protein (ATF/CREB) family (Zhao and
iam, 1992; Suzuki et al., 1993; Adya and Giam, 1995; Yin
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 33 (0)4 67 60 44 20. E-mail: mesnard@crbm.cnrs-mop.fr.277t al., 1995; Reddy et al., 1997; Gachon et al., 1998) to
nhance viral transcription. This trans-activation oper-
tes through three imperfect cAMP response element
CRE)-containing 21-bp regulatory sequences in the
TLV-1 long terminal repeat (LTR). Tax also upregulates
he expression of several cellular genes by activating
ifferent signaling pathways that stimulate effectors
uch as the serum responsive factor and the NF-kB/Rel
actors (for review see Hiscott et al., 1995; Yoshida et al.,
995). Moreover, Tax can repress the transcription of
ellular genes through factors of the basic helix-loop-
elix family (Uittenbogaard et al., 1994; Lemasson et al.,
997).
The mode of leukemic transformation by HTLV-1 is
oorly understood. HTLV-1 does not code for a known
ellular proto-oncogene and has no preferential site of
ntegration, which could explain why a transformation
rocess is initiated. Some published results suggest that
ax not only is a transcriptional activator, but also con-
ributes to the development of ATL. Indirect evidence for
he role of Tax in leukemogenesis comes from studies on
alignant cells from ATL patients, which have defective
roviruses retaining the 39-end of the HTLV-1 genome
Korber et al., 1991). From experiments on primary human
-lymphocyte immortalization by a recombinant herpes-
irus vector carrying the HTLV-1 39 region (Grassmann et
l., 1989), it has been shown that the tax gene is neces-
ary and sufficient for cell immortalization (Grassmann et
l., 1992). Tax can also transform established rodent
ibroblasts (Tanaka et al., 1990; Smith and Greene, 1991;
amaoka et al., 1992, 1996). In addition, cotransfection of
ax with Ras can also induce transformation of primary
at embryo fibroblasts (Pozzatti et al., 1990). Finally, Tax
ransgenic mice develop several pathologies including
eukemia, mesenchymal tumors, and neurofibromas
Hinrichs et al., 1987; Nerenberg et al., 1987; Grossman
t al., 1995; Coscoy et al., 1998).
Modulation of different regulatory pathways and de-0042-6822/99 $30.00
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278 MINIREVIEWegulation of cellular gene expression by Tax might be
mplicated in cell proliferation. However, it remains un-
lear which of the diverse stimulation activities of Tax is
ssential for immortalization of HTLV-1-infected lympho-
ytes. Some reports suggest that NF-kB activation is
ssential for rodent cell transformation (Kitajima et al.,
992; Yamaoka et al., 1996; Matsumoto et al., 1997;
oscoy et al., 1998). Nevertheless, transduction in hu-
an primary T lymphocytes of a Tax mutant that is active
or ATF/CREB but inactive for NF-kB results in permanent
rowth of the cells, suggesting that NF-kB activation by
ax is not a critical component of T-lymphocyte immor-
alization (Rosin et al., 1998). This observation is in
greement with previously published results indicating
hat transcriptional activation through the ATF/CREB
athway could play an important role in Tax-mediated
ellular transformation (Smith and Greene, 1991).
One possible explanation for these results is the Tax-
ependent transcriptional control of the E2F-1 gene
hrough the ATF/CREB pathway (Lemasson et al., 1998).
2F-1 is a transcription factor that belongs to the E2F
amily. The E2F transcriptional activity is the result of the
eterodimeric association of two families of proteins,
2Fs and DPs. Six E2F proteins (E2F1–6) and two DP
ubunits (DP1–2) are characterized in human cells.
2F/DP factors are involved in the transcriptional regu-
ation of genes that encode cell cycle regulatory proteins
La Thangue, 1994, 1996; Slansky and Farnham, 1996)
uch as (i) DNA and chromatin synthesis proteins (dihy-
FIG. 1. Schematic representation of the role of cellular factors involve
entioned in the paper. After mitogen stimulation, D-type cyclins (D1,
yclin–CDK complexes phosphorylate the Rb protein (1). Rb is bound to
ranscription of genes required for transition into S phase (3). As E2F–DP
see text), only E2F is shown for simplicity. This late G1 activation of E2
rans-activation depends on the appearance of cyclin A–CDK2 comple
f its DNA-binding activity. Cyclin A- and D-dependent kinases can be
6) p21WAF1/CIP1. The phosphorylation step is indicated by (MP ). Stimrofolate reductase, thymidine kinase, DNA polymerase
, proliferating cell nuclear antigen, and histone H2A); (ii)
ell cycle regulatory proteins (cyclin A, cyclin E, cyclin
1, p107, pRB, cdc6, hsorc1, E2F-1, and E2F-2); and (iii)
ellular proto-oncogenes including c-myc, N-myc, erb-B,
nd B-myb. Thus ectopic expression of E2F-1 can lead
esting cells to enter into S phase and induce cell pro-
iferation (Johnson et al., 1993; Lukas et al., 1996). In
ddition, Tax is able to strongly potentiate the transcrip-
ional activity of E2F-1 (Lemasson et al., 1998). Mori
1997) suggests that this stimulation could be due to the
nhancement of the DNA-binding activity of E2F factors
y Tax as already described for the ATF/CREB family
Baranger et al., 1995; Yin and Gaynor, 1996). However, it
s obvious that this mechanism is not sufficient to explain
he E2F activation by Tax in HTLV-1-infected cells. In-
eed, E2F activity is known to be regulated by different
ellular proteins whose activities, in turn, are cell cycle
ependent (Fig. 1). Furthermore, Tax has mitogenic ac-
ivity (Schmitt et al., 1998), which regulates cell cycle
rogression, and probably has indirect effects on E2F
ranscriptional activity.
Cell cycle progression is controlled by sequential ac-
ivation of cyclin-dependent protein kinases (CDK) (Van
en Heuvel and Harlow, 1993; Sherr, 1994; Morgan, 1995).
DK4 and CDK6, for example, are the first to be activated
fter serum stimulation and are essential for the control
f G1-phase progression (Fig. 1). CDK4 and CDK6 form
ctive complexes with D-type cyclins (D1, D2, and D3),
ulation of E2F activity. This scheme includes only the cellular proteins
3) associate with their catalytic partners, CDK4 and CDK6. Activated
uring G1. Upon phosphorylation, E2F is released (2) and activates the
dimers are differentially regulated by various members of the Rb family
nes rapidly as cells move into S phase. The reversal of E2F-mediated
ich phosphorylate the E2F1–DP1 heterodimer (4), leading to the loss
ely regulated by specific inhibitors (5): p16INK4A and the p53-inducible
and inhibitory effects are shown by (! ) and (@ ).d in reg
D2, D
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279MINIREVIEWhose synthesis is induced by mitogenic stimulation.
ctivated cyclin D–CDK complexes phosphorylate the
embers of the retinoblastoma tumor suppressor pro-
ein family (Rb, p107, and p130) (Nevins, 1992; Helin and
arlow, 1993). In its hypophosphorylated form, Rb inhib-
ts the transcriptional activity of E2F by formation of a
rotein–protein complex. Phosphorylation of Rb by cyclin
–CDK complexes releases E2Fs, enabling them to ac-
ivate transcription and to stimulate cells to enter S
hase.
In HTLV-1-transformed lymphocytes, the normal cell
ycle is dysregulated. The observations published by
chmitt et al. (1998) clearly demonstrate that Tax is re-
uired to stimulate the G1- to S-phase transition of im-
ortalized T cells. The experiments have been carried
ut with primary human cord blood T cells transduced
ith a recombinant rhadinovirus containing the tax gene
nder a promoter whose expression is repressed by
etracycline. Suppression of Tax synthesis caused cell-
ycle arrest in the G1 phase. After removal of tetracy-
line, the expression of Tax stimulates the G1- to S-phase
ransition of the immortalized T cells. One possible ex-
lanation for this mitogenic effect of Tax is the dissoci-
tion of the Rb–E2F complex by direct binding of Tax to
b as already observed for other oncoviral proteins such
s adenovirus E1A protein, simian virus 40 large T anti-
en, and papillomavirus E7. However, studies involving
n vitro binding assays indicate that Tax does not interact
ith Rb directly (Low et al., 1997). Another possibility is
he stimulation of expression levels of CDK4, CDK6, and
yclin D isotypes by Tax. However, no transcription stim-
lation of the genes coding for these proteins has been
bserved (Suzuki et al., 1996; Neuveut et al., 1998;
chmitt et al., 1998) although these observations conflict
ith the conclusions drawn by Akagi et al. (1996), who
ypothesized that the promoter of cyclin D2 might be
ctivated by Tax. A third possible mechanism is the
ctivation of CDK4 and CDK6 by Tax. Indeed, in the
resence of Tax, both CDK4 and CDK6 activities are
timulated (Schmitt et al., 1998) and Rb is hyperphospho-
ylated (Neuveut et al., 1998).
The activities of cyclin D–CDK complexes are regu-
ated by specific factors called INK4 proteins (for Inhibi-
ors of CDK4), which bind to CDK4 and CDK6 and block
heir kinase activities (Fig. 1). As a consequence, the cell
ycle is arrested in the G1 phase. This family of inhibitors
ncludes p16INK4A, p15INK4B, p18INK4C, and p19INK4D (Peter
nd Herskowitz, 1994; Morgan, 1995; Sherr and Roberts,
995). Tax could activate CDK4 and CDK6 by counteract-
ng the INK4 protein inhibitory function. As Tax binds to
he ankyrin motifs of IkBa, it has been postulated that
ax could also interact with the ankyrin motif in p16INK4A
Suzuki et al., 1996). Indeed, it has been shown that Tax
orms a complex with p16INK4A and that this interaction
nterferes with the ability of p16INK4A to repress CDK4
inase activity (Suzuki et al., 1996; Low et al., 1997). As itas been reported that the p16 gene is deleted or
utated in many human tumor cell lines (Sherr and
oberts, 1995), it may be argued that p16INK4A is not a
elevant target for Tax in vivo. However, expression of the
16INK4A gene is in fact not altered in the HTLV-1-trans-
ormed T-cell lines (Suzuki et al., 1996). Therefore the
unctional inactivation of p16INK4A by Tax could play an
mportant role in proliferation of established T-cell lines
nfected by HTLV-1. On the other hand, it has been dem-
nstrated that Tax is unable to interact with other mem-
ers of the INK4 family such as p18INK4C and p19INK4D
Neuveut et al., 1998).
However, in Jurkat cells, which lack expression of
16INK4A, Tax remains able to stimulate the G1- to S-
hase transition despite the absence of serum and to
ncrease CDK4 and CDK6 activities (Neuveut et al., 1998).
hese results suggest that Tax is able to activate CDK4
nd CDK6 by a p16INK4A-independent pathway. Neuveut
t al. (1998) have recently found that Tax can form a
omplex with cyclin D3 and induces cyclin D3 phosphor-
lation. They proposed that binding by Tax could, through
nknown processes, affect cyclin D3 phosphorylation.
hosphorylated cyclin D3 could render the cyclin–CDK
omplexes more active and thus stimulate cell cycle
rogression. However, cyclin phosphorylation has been
eported to be a signal for ubiquitination and proteasome
rocessing (Clurman et al., 1996; Won and Reed, 1996;
iehl et al., 1997). Indeed, phosphorylation of cyclin D1
nd E on Thr286 and Thr380, respectively, regulates
yclin destruction (Won and Reed, 1996; Diehl et al.,
997). Characterization of the exact site of phosphoryla-
ion seems to be essential to confirm this model. In
onclusion, Tax is able to deregulate the cell cycle pro-
ression by targeting different levels, including transcrip-
ion regulation as well as direct interaction with p16INK4A
nd cyclin D3. However, the link between these results
btained in established cell lines and the development of
TL still remains to be clearly demonstrated.
Cell cycle progression is also controlled by p53, which
s a tumor suppressor. p53 is a transcriptional nuclear
hosphoprotein activated in response to DNA damage
Fig. 2). Induction of p53 results in either cellular arrest in
1 (mediated by the CDK inhibitor p21
WAF1/CIP1, for in-
tance) or apoptosis (mediated by the tumor suppressor
ax, for example) (Gottlieb and Oren, 1996; Ko and
rives, 1996; Evan and Littlewood, 1998). It is therefore
ot surprising that the p53 gene is the most frequently
utated gene in human cancer. Although missense mu-
ations have been described in the p53 gene of ATL cells,
he frequency of such mutations is low and such muta-
ions are found in only 20% of cells (Nagai et al., 1991;
ugito et al., 1991; Sakashita et al., 1992). These obser-
ations suggest that in addition to mutation another
echanism is probably involved that acts by preventing
53 expression or function in HTLV-1-transformed T
ells. Concerning the possibility that the mechanism
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280 MINIREVIEWnvolves the inhibition of p53 expression, it has been
roposed that Tax could repress p53 transcription (Uit-
enbogaard et al., 1995) as already shown for the genes
ncoding b-polymerase, p56lck kinase, and Bax (Jeang et
l., 1990; Brauweiler et al., 1997; Lemasson et al., 1997).
owever, elevated expressions of p53 found in several
TLV-1-transformed T-lymphocyte lines (Reid et al., 1993;
amato et al., 1993; Gartenhaus and Wang, 1995) and
ax-immortalized T cells (Akagi et al., 1997) do not sup-
ort this hypothesis. Moreover, the half-life of p53 is
ncreased in HTLV-1-transformed T-lymphocytes (Reid et
l., 1993) compared with the rapid turnover observed in
ormal cells. On the other hand, data obtained from
ransfection experiments using a p53-responsive re-
orter plasmid and from ionizing radiation studies dem-
nstrate that p53 is not fully active in HTLV-1-transformed
ymphocytes and that Tax alone is capable of suppress-
ng the p53 transcriptional activity (Cereseto et al., 1996;
kagi et al., 1997; Mulloy et al., 1998; Pise-Masison et al.,
998a). In addition, Tax abrogates G1 arrest and apopto-
is induced by p53 (Mulloy et al., 1998). These observa-
ions lend support to the hypothesis of functional inhibi-
ion of p53 by Tax, but the molecular mechanism by
hich this inhibition occurs is unknown. Some viral on-
oproteins, such as adenovirus E1B 55K, simian virus 40
arge T antigen, and papillomavirus E6 protein, inactivate
53 by direct binding. However, this mechanism is prob-
bly not used by HTLV-1 since no association between
53 and Tax has been characterized (Yamato et al., 1993).
oreover, Tax does not interfere with the nuclear local-
zation or DNA-binding ability of p53 (Mulloy et al., 1998;
ise-Masison et al., 1998b). Alternatively, Tax could reg-
late p53 by posttranscriptional modification. Pise-
asison et al. (1998b) have recently suggested that Tax
ould regulate p53 by increasing the ability of a kinase to
hosphorylate residues Ser15 and Ser392 of p53. This
yperphosphorylated form of p53 is unable to interact in
ivo with the TATA box-binding protein or Mdm-2 (Fig. 2),
hich is normally involved in p53 degradation (Pise-
asison et al., 1998b). Finally, Tax could regulate p53 by
n indirect effect. Indeed, Tax stimulates transcription of
FIG. 2. Control of p53 activity. After activation by stress such as DNA
amage, p53 induces transcription of genes encoding proteins that
ediate either growth arrest (for instance, p21WAF1/CIP1) or apoptosis
for example, Bax). The level of p53 is regulated through interaction with
he Mdm-2 protein, which signals its degradation. Stimulating and
nhibitory effects are shown by (! ) and (@ ).he viral promoter by recruiting the coactivator CREB-
inding protein (CBP) (Kwok et al., 1996; Giebler et al.,
997; Bex et al., 1998) and by interacting with basal
ranscription factors (Caron et al., 1993, 1997; Clemens et
l., 1996). Thus, Tax could inhibit p53 through competition
or common transcriptional regulators. Recently, Colgin
nd Nyborg (1998) demonstrated that Tax was able to
ntagonize the transcriptional activity of c-Myb by com-
eting for CBP binding. These results confirm that such
mechanism could also be involved in the deregulation
f p53 transcriptional activity by Tax.
A major part of p53-mediated growth arrest proceeds
hrough stimulation of the CDK inhibitor p21WAF1/CIP1,
hich regulates the cell cycle by inhibiting the CDKs (Fig.
) required for progression from the G1 to the S phase
El-Deiry et al., 1993; Harper et al., 1993) and also inhibits
he ability of proliferating-cell nuclear antigen to activate
NA polymerase d, resulting in inhibition of DNA repli-
ation (Waga et al., 1994). However, p21WAF1/CIP1 expres-
ion is highly stimulated in HTLV-1-transformed T-cell
ines (Akagi et al., 1996; Cereseto et al., 1996). Although
his observation may be unexpected, elevated levels of
21WAF1/CIP1 have already been reported in transformed
ells. For example, papillomavirus E7 oncoprotein-ex-
ressing keratinocytes overexpress p21WAF1/CIP1, but E7
s able to overcome p21WAF1/CIP1 arrest (Morozov et al.,
997; Ruesch and Laimins, 1997). It has been proposed
hat E7 abrogates G1/S arrest by interacting with
21WAF1/CIP1 (Jones et al., 1997), but this result is still a
atter of controversy (Ruesch and Laimins, 1997). It is
ossible that E7 overcomes G1/S arrest without directly
ffecting p21 function and acts through deregulation of
2F activity by interacting with Rb (Ruesch and Laimins,
997). A similar control mechanism is probably involved
n the case of HTLV-1 since Tax can also stimulate E2F
ctivity (Lemasson et al., 1998; Mori, 1997). The existence
f an indirect mechanism is supported by the observa-
ion that Tax does not interact physically with p21WAF1/CIP1
Parker et al., 1996; Low et al., 1997). It remains intriguing,
owever, that Tax stimulates expression of p21WAF1/CIP1
n infected T cells. This fact probably means that
21WAF1/CIP1 might play an important role in the activation
f T cells by Tax, one possibility being that p21WAF1/CIP1 is
nvolved in stimulation of NF-kB activity (Perkins et al.,
997) and can cooperate with Tax to stimulate the NF-kB
athway (Parker et al., 1996).
Reports on the capacity of Tax to mediate apoptosis
re contradictory. Although Copeland et al. (1994) have
ound that susceptible T cells, transfected with a Tax-
xpressing vector or treated with soluble Tax, become
ess susceptible to anti-Fas-induced cell death, other
nvestigators have demonstrated that Tax has a potential
poptotic effect (Yamada et al., 1994; Chlichlia et al.,
995, 1997; Fujita and Shiku, 1995; Los et al., 1998). The
olecular mechanism of Tax-induced apoptosis could
nvolve Fas, a receptor on the surface of lymphocytes
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281MINIREVIEWhat induces apoptosis upon binding to Fas ligand, FasL
Ashkenazi and Dixit, 1998). Tax has been shown to
pregulate the FasL gene and thus to induce apoptosis
Chen et al., 1997; Rivera et al., 1998). However, the
artial blockade of apoptosis by antibodies specific for
nteraction of FasL with its receptor indicates that the
inding to FasL is not the major pathway of Tax-mediated
poptosis (Chlichlia et al., 1997). On the other hand, the
ax effect was completely blocked by zVAD-fmk, a spe-
ific inhibitor of ICE (interleukin-1b-converting enzyme)-
ike proteases, suggesting that the apoptotic action of
ax requires ICE protease function (Chlichlia et al., 1997).
hus it appears that Tax can activate both pro- and
nti-apoptotic pathways, with the latter pathway being
ominant in immortalized T cells. Consistent with this
dea, oncogenic Ras has been shown to initiate a p53-
ndependent apoptotic response that is suppressed
hrough the activation of NF-kB (Mayo et al., 1997). The
timulation of the NF-kB pathway by Tax could also be
nvolved in a similar mechanism. Recent results obtained
ith CTLL-2, a mouse T-cell line, confirm this hypothesis.
TLL-2 cell lines expressing wild-type Tax or a Tax mu-
FIG. 3. Schematic representation of the activities of Tax that control
16INK4A (2). Tax also interacts with cyclin D3, stabilizing the CDK–cycli
K6), which phosphorylate Rb (4). Phosphorylation of Rb destabilizes the
6). These genes code for proteins required for G1- to S-phase transition
2F-1. The transcription of the last protein is also stimulated by Ta
nappropriate entry into S phase (8), but Tax prevents p53-dependent in
f the cell cycle blocked by Tax are shown by ( ). The phosphorylation s
Á
! ) and (@ ).ant, which is still an activator of NF-kB, are resistant to
poptosis induced in the absence of IL-2 (Iwanaga et al.,
999). On the other hand, a Tax mutant, which is active
or ATF/CREB but inactive for NF-kB, enhances apopto-
is in the absence as well as in the presence of IL-2.
DNA oncoviruses encode proteins that inactivate Rb
nd p53, both proteins inhibiting progression to the S
hase of the cell cycle. For instance, the adenovirus E1A
timulates the G1- to S-phase transition by inactivating
b. The inappropriate entry into S phase activates p53,
ausing growth arrest or apoptosis. However, two E1B
roteins, p19 and p55, inhibit p53-mediated apoptosis.
1B 19K acts as a functional homolog of Bcl-2, whereas
1B 55K binds to p53 and inhibits its transcriptional
ctivity (Evan and Littlewood, 1998; Linke, 1998). HTLV-1
as also developed its own strategy to counteract Rb
nd p53 functions (Fig. 3). HTLV-1 can stimulate the
yperphosphorylation of Rb by two independent mecha-
isms, both controlled by Tax. Tax can, at first, interact
ith p16INK4A to block its inhibitory activity and, second,
timulate CDK4 and CDK6 activities, perhaps by stabiliz-
ng the cyclin–CDK complexes as suggested for cyclin
liferation. Tax binds to p16INK4A (1) and blocks the inhibitory activity of
mplex (3). These events stimulate the activity of CDK4 (K4) and CDK6
F association (5) and stimulates expression of genes controlled by E2F
s dihydrofolate reductase (DHFR), thymidine kinase (TK), cyclin E, and
gh the ATF/CREB pathway (7). Overexpression of E2F-1 promotes
n of apoptosis or growth arrest by inhibiting p53 activity (9). The steps
ndicated by (MP ). Stimulating and inhibitory effects are shown bycell pro
n D3 co
Rb–E2
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282 MINIREVIEW3 (Neuveut et al., 1998). Moreover, Tax, through the
TF/CREB pathway, can activate the transcription of the
ene encoding E2F-1. All these events favor overexpres-
ion of E2F-1, which then induces a p53-dependent apop-
osis (Qin et al., 1994; Wu and Levine, 1994). However,
ax is also able to inactivate p53 by a mechanism that, at
resent, remains unknown. It is noteworthy that HTLV-1
odes for only one viral protein that inhibits Rb and p53,
hereas adenovirus encodes three different proteins
hat have the same effect. It is likely that the explanation
esides in the difference in genome size between the two
iruses. Since HTLV-1 has a genome that is much
maller than that of adenovirus, it is probably an advan-
age for the virus to code for a multifunctional protein
uch as Tax. However, the existence of other viral pro-
eins encoded by the 39 end of the HTLV-1 genome has
een described (Koralnik et al., 1992), and we cannot
xclude the possibility that among these proteins one
ould also be involved in cell proliferation either directly
r indirectly. For instance, HTLV-1 p12I is able to coop-
rate with the bovine papillomavirus E5 oncoprotein to
ransform mouse cells (Franchini et al., 1993).
Recent results suggest also a dysregulation by Tax of
he G2–M checkpoint of the cell cycle. By interacting with
rotein MAD1 (mitotic arrest-defective) which is involved
n the G2–M transition control, Tax would inhibit MAD1
unction (Jin et al., 1998). This observation could explain
he karyotypic abnormalities present in ATL cells. Thus,
ot only does Tax force infected cells into S phase but
ax could also dysregulate the G2–M transition. The
uccession of both events could contribute to the trans-
ormation of T cells by HTLV-1.
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